Literature DB >> 22316239

Natural products as sources of new drugs over the 30 years from 1981 to 2010.

David J Newman1, Gordon M Cragg.   

Abstract

This review is an updated and expanded version of the three prior reviews that were published in this journal in 1997, 2003, and 2007. In the case of all approved therapeutic agents, the time frame has been extended to cover the 30 years from January 1, 1981, to December 31, 2010, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2010 for all approved antitumor drugs worldwide. We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions and have added a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixtures" that have now been recognized as drug entities by the FDA and similar organizations. From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well. Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 175 small molecules, 131, or 74.8%, are other than "S" (synthetic), with 85, or 48.6%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. Although combinatorial chemistry techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compound approved as a drug in this 30-year time frame. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22316239      PMCID: PMC3721181          DOI: 10.1021/np200906s

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  92 in total

1.  Asymmetric solid-phase synthesis of 6,6-spiroketals.

Authors:  Okram Barun; Stefan Sommer; Herbert Waldmann
Journal:  Angew Chem Int Ed Engl       Date:  2004-06-14       Impact factor: 15.336

Review 2.  Enhancements of screening collections to address areas of unmet medical need: an industry perspective.

Authors:  David H Drewry; Ricardo Macarron
Journal:  Curr Opin Chem Biol       Date:  2010-04-21       Impact factor: 8.822

Review 3.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

4.  Enantioselective total syntheses of (-)-palau'amine, (-)-axinellamines, and (-)-massadines.

Authors:  Ian B Seiple; Shun Su; Ian S Young; Akifumi Nakamura; Junichiro Yamaguchi; Lars Jørgensen; Rodrigo A Rodriguez; Daniel P O'Malley; Tanja Gaich; Matthias Köck; Phil S Baran
Journal:  J Am Chem Soc       Date:  2011-08-23       Impact factor: 15.419

5.  Transarterial chemoembolization with miriplatin-lipiodol emulsion for neuroendocrine metastases of the liver.

Authors:  Jin Iwazawa; Shoichi Ohue; Keigo Yasumasa; Takashi Mitani
Journal:  World J Radiol       Date:  2010-12-28

6.  Genomic mining for Aspergillus natural products.

Authors:  Jin Woo Bok; Dirk Hoffmeister; Lori A Maggio-Hall; Renato Murillo; Jeremy D Glasner; Nancy P Keller
Journal:  Chem Biol       Date:  2006-01

7.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

8.  Screening of species of the endophytic fungus Phomopsis for the production of the anticancer drug taxol.

Authors:  Rangarajulu Senthil Kumaran; Byung-Ki Hur
Journal:  Biotechnol Appl Biochem       Date:  2009-07-06       Impact factor: 2.431

Review 9.  Influenza neuraminidase: a druggable target for natural products.

Authors:  Ulrike Grienke; Michaela Schmidtke; Susanne von Grafenstein; Johannes Kirchmair; Klaus R Liedl; Judith M Rollinger
Journal:  Nat Prod Rep       Date:  2011-10-25       Impact factor: 13.423

10.  Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity.

Authors:  Qi-Yin Chen; Yanxia Liu; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2011-08-31       Impact factor: 4.345

View more
  1098 in total

1.  Investigation of Vietnamese plants for potential anticancer agents.

Authors:  Lynette Bueno Pérez; Patrick C Still; C Benjamin Naman; Yulin Ren; Li Pan; Hee-Byung Chai; Esperanza J Carcache de Blanco; Tran Ngoc Ninh; Bui Van Thanh; Steven M Swanson; Djaja D Soejarto; A Douglas Kinghorn
Journal:  Phytochem Rev       Date:  2014-12       Impact factor: 5.374

Review 2.  Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.

Authors:  Enoche F Oga; Shuichi Sekine; Yoshihisa Shitara; Toshiharu Horie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-04       Impact factor: 2.441

3.  Integration of high-content screening and untargeted metabolomics for comprehensive functional annotation of natural product libraries.

Authors:  Kenji L Kurita; Emerson Glassey; Roger G Linington
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-14       Impact factor: 11.205

Review 4.  Leveraging ecological theory to guide natural product discovery.

Authors:  Michael J Smanski; Daniel C Schlatter; Linda L Kinkel
Journal:  J Ind Microbiol Biotechnol       Date:  2015-10-05       Impact factor: 3.346

5.  Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.

Authors:  Jianlan You; Lin Du; Jarrod B King; Brian E Hall; Robert H Cichewicz
Journal:  ACS Chem Biol       Date:  2013-02-14       Impact factor: 5.100

6.  Quantitative molecular networking to profile marine cyanobacterial metabolomes.

Authors:  Jacob R Winnikoff; Evgenia Glukhov; Jeramie Watrous; Pieter C Dorrestein; William H Gerwick
Journal:  J Antibiot (Tokyo)       Date:  2013-11-27       Impact factor: 2.649

7.  Elaeocarpus reticulatus fruit extracts reduce viability and induce apoptosis in pancreatic cancer cells in vitro.

Authors:  Alexandria Turner; Danielle R Bond; Quan V Vuong; Anita Chalmers; Emma L Beckett; Judith Weidenhofer; Christopher J Scarlett
Journal:  Mol Biol Rep       Date:  2020-02-17       Impact factor: 2.316

Review 8.  Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Authors:  Sandeep Kumar Singh; Saurabh Srivastav; Rudolph J Castellani; Germán Plascencia-Villa; George Perry
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

9.  Effect of neovestitol-vestitol containing Brazilian red propolis on accumulation of biofilm in vitro and development of dental caries in vivo.

Authors:  B Bueno-Silva; H Koo; M L Falsetta; S M Alencar; M Ikegaki; P L Rosalen
Journal:  Biofouling       Date:  2013-10-07       Impact factor: 3.209

10.  Enantioselective synthesis of angularly substituted 1-azabicylic rings: coupled dynamic kinetic epimerization and chirality transfer.

Authors:  Zachary D Aron; Tatsuya Ito; Tricia L May; Larry E Overman; Jocelyn Wang
Journal:  J Org Chem       Date:  2013-09-10       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.